⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of FAMAR Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
FAMAR Group
↗Alimos, Greece
FAMAR is a prominent European Contract Development and Manufacturing Organization (CDMO) with over 75 years of experience in the pharmaceutical and healthcare industries. The company provides end-to-end solutions, including pharmaceutical development, analytical testing, commercial manufacturing, packaging, and logistics for a wide range of dosage forms such as sterile liquids, solids, semi-solids, and non-sterile liquids.
Operating through a network of seven GMP-compliant manufacturing sites and two development centers across Greece, Italy, Spain, and Germany, FAMAR serves more than 120 customers and supplies over 1,700 products to more than 80 international markets. The company is known for its customer-centric approach and has recently expanded its capabilities in high-value dosage forms, including aseptic and lyophilized fill & finish.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:-
Industry:CDMO
Sub-Industry:Pharmaceutical Manufacturing & Development
SIZE & FINANCIALS
Employees:1001-5000
Founded:1949
Ownership:private
Status:operating
FUNDING
Investors:MidEuropa
PIPELINE
Modalities:Small molecule, Sterile injectables, Solid dosage, Semi-solids
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:MidEuropa
Acquired By:MidEuropa (2024-10-01)
Key Partnerships:GE HealthCare (Manufacturing agreement for contrast media)
COMPETITION
Position:Leader
Competitors:Recipharm, Adragos Pharma
LEADERSHIP
Key Executives:
Dr. Riku Rautsola - CEO
Isabelle Lafosse-Marin - Group COO
LINKS
Website:famar-group.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with FAMAR Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.